-+ 0.00%
-+ 0.00%
-+ 0.00%

ERNEXA THERAPEUTICS CEO CORNER HIGHLIGHTS DIFFERENTIATED ERNA-101 PLATFORM AS COMPANY ADVANCES TOWARD PLANNED FIRST-IN-HUMAN PHASE 1 STUDY IN 2026

路透·07/14/2026 13:01:00

登录查看新闻详情